These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6033897)

  • 21. A study of 'Menopax Forte' in menopausal and postmenopausal disorders.
    Souza JM; Patil BJ
    Indian Pract; 1966 Dec; 19(12):795-8. PubMed ID: 5980860
    [No Abstract]   [Full Text] [Related]  

  • 22. Potency of quinestrol as reflected by vaginal cytologic maturation.
    Hammond D
    Int J Fertil; 1967; 12(2):164-9. PubMed ID: 6033893
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of quinestrol on the coagulation mechanism.
    Lenahan JG; Stough A; Bronstein SB
    Int J Fertil; 1967; 12(2):271-3. PubMed ID: 5342278
    [No Abstract]   [Full Text] [Related]  

  • 24. A study on ovulation inhibition by quinestrol.
    Arronet GH; Arrata WS; Latour JP; Broda S
    Int J Fertil; 1969; 14(4):295-9. PubMed ID: 5824020
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ethinyl estradiol 3-cyclopentyl ether in single doses in the treatment of the climateric].
    Guixa HL; Cronenberg EM; Faccone JG; De la Parra I
    Prensa Med Argent; 1971 Dec; 58(40):1968-76. PubMed ID: 5137766
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of estrogens at high dosage on the human endometrium.
    Egger H; Kindermann G
    Arch Gynakol; 1974 Jul; 216(4):399-408. PubMed ID: 4211956
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model.
    Slayden OD; Zelinski MB; Chwalisz K; Hess-Stumpp H; Brenner RM
    Hum Reprod; 2006 Dec; 21(12):3081-90. PubMed ID: 16936297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of selected cytologic indices for evaluation of estrogenicity of synthetic compounds.
    Teter J
    Acta Cytol; 1972; 16(4):366-75. PubMed ID: 4556412
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current value of endometrial biopsy].
    Yaneva H
    Contracept Fertil Sex; 1994 Feb; 22(2):132-4. PubMed ID: 8199646
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and efficacy of an extended-regimen oral contraception utilizing low-dose ethinyl estradiol.
    Anderson FD
    Contraception; 2006 Oct; 74(4):355. PubMed ID: 16982247
    [No Abstract]   [Full Text] [Related]  

  • 31. Reliability of endometrial aspiration cytology in the assessment of endometrial status.
    Morse AR; Ellice RM; Anderson MC; Beard RW
    Obstet Gynecol; 1982 Apr; 59(4):513-8. PubMed ID: 7043343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of estrogen properties of quinestrol in human females.
    Roland M; Clyman MJ; Decker A; Ober WB; Bronstein SB
    Int J Fertil; 1967; 12(2):176-80. PubMed ID: 6033894
    [No Abstract]   [Full Text] [Related]  

  • 33. Endometrial patterns and endocrinologic characteristics of asymptomatic menopausal women.
    Göl K; Saraçoğlu F; Ekici A; Sahin I
    Gynecol Endocrinol; 2001 Feb; 15(1):63-7. PubMed ID: 11293927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous estrogen therapy. Endometrial response and metabolic effects.
    Holst J
    Acta Obstet Gynecol Scand Suppl; 1983; 115():1-30. PubMed ID: 6574685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic effects of various doses of ethinyl estradiol in postmenopausal women.
    Mandel FP; Geola FL; Lu JK; Eggena P; Sambhi MP; Hershman JM; Judd HL
    Obstet Gynecol; 1982 Jun; 59(6):673-9. PubMed ID: 6281707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women.
    Filho AM; Barbosa IC; Maia H; Genes CC; Coutinho EM
    Gynecol Endocrinol; 2007 Sep; 23(9):511-7. PubMed ID: 17943546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin, hormone replacement therapy, and breast cancer.
    Notelovitz M
    Am J Obstet Gynecol; 1983 Jul; 146(6):740-1. PubMed ID: 6869445
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
    Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC
    Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of a combination of gestoden-ethylene estradiol on the endometrium].
    Vázquez Benítez E; Sereno Colo JA; Andrade Sánchez A; Vázquez Martínez JE; Chávez López A; Bruciaga Montes V
    Ginecol Obstet Mex; 1993 Sep; 61():265-7. PubMed ID: 8406113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.